ACCESS HYBRITECH P2PSA ON THE ACCESS IMMUNOASSAY SYSTEMS
FDA premarket approval P090026/S017 · decided 2017-02-21
Approval details
- PMA number
- P090026
- Supplement
- S017
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- ACCESS HYBRITECH P2PSA ON THE ACCESS IMMUNOASSAY SYSTEMS
- Generic name
- P2psa
- Applicant
- Beckman Coulter, Inc.
- Date received
- 2017-01-23
- Decision date
- 2017-02-21
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- OYA
- Advisory committee
- Immunology
- Expedited review
- No
- Location
- Chaska, MN
- Statement
- Manufacturing process change to the Working Strength Particle Batch Size process, which is used in the paramagnetic particle (PMP) for use in the Access Hybritech p2PSA Reagent.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| Access BNP II (K252169) | Beckman Coulter, Inc. | 2026-03-24 |
| Access anti-HBc IgM (K254059) | Beckman Coulter, Inc. | 2026-03-13 |
| Access anti-HBc Total (K253687) | Beckman Coulter, Inc. | 2026-02-19 |
| Access anti-HAV IgM (K251995) | Beckman Coulter, Inc. | 2026-01-27 |
| Access Rubella IgG (K250588) | Beckman Coulter, Inc. | 2025-11-17 |
| iQ200 Series (K252580) | Beckman Coulter, Inc. | 2025-09-10 |
| Access anti-HAV (K243846) | Beckman Coulter, Inc. | 2025-09-09 |
| MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL) (MicroScan) (K243804) | Beckman Coulter, Inc. | 2025-08-20 |